Gut microbiome and short-chain fatty acids associated with the efficacy of growth hormone treatment in children with short stature.

First, the relatively small sample size ( n = 61), particularly in the subgroup with the highest efficacy (>97th percentile), may reduce statistical power and introduce bias in the assessment of metabolic heterogeneity (e.g., the difference in butyrate did not reach statistical significance).

also in 111,027 other papers